AR and posterior cortical atrophy: Conversely, non-AR-mediated mechanisms appear to be more heterogeneous (2) and may manifest as treatment-emergent evolution into AR-indifferent phenotypes such as small-cell neuroendocrine (NE) (9–14) or AR-negative, NE-negative (double-negative) PCa (11, 15–17).